BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Lupin Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500257
ISIN Demat
INE326A01037
Book Value (Rs)
595.4470362
NSE Symbol
LUPIN
Divident Yield %
0.49
Market Cap
(Rs In Cr.)
111,668
P/E (TTM)
20.19
EPS (TTM)
120.94
Face Value
(Rs)
2
Date Heading
05-May-26 Lupin wins USFDA approval for Glycerol Phenylbutyrate oral liquid
04-May-26 Lupin allots 36,752 equity shares under ESOP
23-Apr-26 Lupin to convene board meeting
22-Apr-26 Lupin launches diabetes drug in U.S. after FDA nod
18-Apr-26 Lupin's New Jersey-based facility gets Form-483 with three observation
17-Apr-26 Lupin's US arm enters into USD 30 million settlement agreement with Hu
17-Apr-26 Lupin's US arm settles civil antitrust litigation with Humana for $30
17-Apr-26 Lupin incorporates WoS in Thailand
13-Apr-26 Lupin launches generic Dapagliflozin tablets in US after FDA nod
09-Apr-26 Lupin grants 6,495 stock options under ESOP
09-Apr-26 Lupin gets USFDA nod for Dapagliflozin and Metformin ER tablets
08-Apr-26 Lupin receives USFDA approval for Dapagliflozin and Metformin Hydrochl
06-Apr-26 Lupin Ltd down for fifth straight session
09-Mar-26 Lupin slips as Ankleshwar facility gets two observations from US FDA
27-Feb-26 Lupin receives EIR report with VAI classification for its Goa unit
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)